Belite Bio to uplist to Nasdaq Global Select Market
- Belite Bio (BLTE) has received approval from Nasdaq to transfer the listing of its securities from the Nasdaq Capital Market to the Nasdaq Global Select Market.
- Trading on the Nasdaq Global Select Market will commence at market open on October 19, 2026, under the company's existing ticker symbol “BLTE.”
Recommended For You
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Create Your Free Account to Keep Reading
Get the confidence to navigate an uncertain market with free breaking news and stock alerts.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.